nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefuroxime—SLC15A1—Lisinopril—systemic scleroderma	0.421	0.572	CbGbCtD
Cefuroxime—SLC15A1—Captopril—systemic scleroderma	0.315	0.428	CbGbCtD
Cefuroxime—Muscle spasms—Lisinopril—systemic scleroderma	0.000367	0.00139	CcSEcCtD
Cefuroxime—Rash—Pentoxifylline—systemic scleroderma	0.000366	0.00139	CcSEcCtD
Cefuroxime—Dermatitis—Pentoxifylline—systemic scleroderma	0.000366	0.00139	CcSEcCtD
Cefuroxime—Headache—Pentoxifylline—systemic scleroderma	0.000364	0.00138	CcSEcCtD
Cefuroxime—Thrombophlebitis—Methotrexate—systemic scleroderma	0.000364	0.00138	CcSEcCtD
Cefuroxime—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000363	0.00138	CcSEcCtD
Cefuroxime—Chest pain—Mycophenolic acid—systemic scleroderma	0.000361	0.00137	CcSEcCtD
Cefuroxime—Arthralgia—Mycophenolic acid—systemic scleroderma	0.000361	0.00137	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Captopril—systemic scleroderma	0.00036	0.00136	CcSEcCtD
Cefuroxime—Irritability—Prednisone—systemic scleroderma	0.00036	0.00136	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.000359	0.00136	CcSEcCtD
Cefuroxime—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000355	0.00135	CcSEcCtD
Cefuroxime—Pruritus—Mometasone—systemic scleroderma	0.000355	0.00134	CcSEcCtD
Cefuroxime—Tachycardia—Leflunomide—systemic scleroderma	0.000354	0.00134	CcSEcCtD
Cefuroxime—Skin disorder—Leflunomide—systemic scleroderma	0.000352	0.00134	CcSEcCtD
Cefuroxime—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000351	0.00133	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00035	0.00133	CcSEcCtD
Cefuroxime—Angioedema—Lisinopril—systemic scleroderma	0.000349	0.00132	CcSEcCtD
Cefuroxime—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.000349	0.00132	CcSEcCtD
Cefuroxime—Body temperature increased—Captopril—systemic scleroderma	0.000348	0.00132	CcSEcCtD
Cefuroxime—Abdominal pain—Captopril—systemic scleroderma	0.000348	0.00132	CcSEcCtD
Cefuroxime—Anorexia—Leflunomide—systemic scleroderma	0.000346	0.00131	CcSEcCtD
Cefuroxime—Nausea—Pentoxifylline—systemic scleroderma	0.000345	0.00131	CcSEcCtD
Cefuroxime—Chills—Mycophenolate mofetil—systemic scleroderma	0.000345	0.00131	CcSEcCtD
Cefuroxime—Diarrhoea—Mometasone—systemic scleroderma	0.000343	0.0013	CcSEcCtD
Cefuroxime—Leukopenia—Lisinopril—systemic scleroderma	0.000342	0.0013	CcSEcCtD
Cefuroxime—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000339	0.00128	CcSEcCtD
Cefuroxime—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000338	0.00128	CcSEcCtD
Cefuroxime—Palpitations—Lisinopril—systemic scleroderma	0.000338	0.00128	CcSEcCtD
Cefuroxime—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000336	0.00127	CcSEcCtD
Cefuroxime—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000335	0.00127	CcSEcCtD
Cefuroxime—Cough—Lisinopril—systemic scleroderma	0.000333	0.00126	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000332	0.00126	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000331	0.00125	CcSEcCtD
Cefuroxime—Anorexia—Mycophenolic acid—systemic scleroderma	0.00033	0.00125	CcSEcCtD
Cefuroxime—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.00033	0.00125	CcSEcCtD
Cefuroxime—Arthralgia—Lisinopril—systemic scleroderma	0.000325	0.00123	CcSEcCtD
Cefuroxime—Chest pain—Lisinopril—systemic scleroderma	0.000325	0.00123	CcSEcCtD
Cefuroxime—Dyspnoea—Leflunomide—systemic scleroderma	0.000323	0.00123	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000323	0.00122	CcSEcCtD
Cefuroxime—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000322	0.00122	CcSEcCtD
Cefuroxime—Dyspepsia—Leflunomide—systemic scleroderma	0.000319	0.00121	CcSEcCtD
Cefuroxime—Vomiting—Mometasone—systemic scleroderma	0.000319	0.00121	CcSEcCtD
Cefuroxime—Rash—Mometasone—systemic scleroderma	0.000316	0.0012	CcSEcCtD
Cefuroxime—Dermatitis—Mometasone—systemic scleroderma	0.000316	0.0012	CcSEcCtD
Cefuroxime—Decreased appetite—Leflunomide—systemic scleroderma	0.000315	0.0012	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000315	0.0012	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000314	0.00119	CcSEcCtD
Cefuroxime—Headache—Mometasone—systemic scleroderma	0.000314	0.00119	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000313	0.00119	CcSEcCtD
Cefuroxime—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000312	0.00118	CcSEcCtD
Cefuroxime—Pruritus—Captopril—systemic scleroderma	0.000311	0.00118	CcSEcCtD
Cefuroxime—Pain—Leflunomide—systemic scleroderma	0.00031	0.00118	CcSEcCtD
Cefuroxime—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000309	0.00117	CcSEcCtD
Cefuroxime—Somnolence—Mycophenolic acid—systemic scleroderma	0.000308	0.00117	CcSEcCtD
Cefuroxime—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000308	0.00117	CcSEcCtD
Cefuroxime—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000306	0.00116	CcSEcCtD
Cefuroxime—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000305	0.00116	CcSEcCtD
Cefuroxime—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000305	0.00115	CcSEcCtD
Cefuroxime—Neutropenia—Prednisone—systemic scleroderma	0.000304	0.00115	CcSEcCtD
Cefuroxime—Tachycardia—Lisinopril—systemic scleroderma	0.000304	0.00115	CcSEcCtD
Cefuroxime—Abdominal pain—Azathioprine—systemic scleroderma	0.000304	0.00115	CcSEcCtD
Cefuroxime—Body temperature increased—Azathioprine—systemic scleroderma	0.000304	0.00115	CcSEcCtD
Cefuroxime—Skin disorder—Lisinopril—systemic scleroderma	0.000303	0.00115	CcSEcCtD
Cefuroxime—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000301	0.00114	CcSEcCtD
Cefuroxime—Diarrhoea—Captopril—systemic scleroderma	0.000301	0.00114	CcSEcCtD
Cefuroxime—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000301	0.00114	CcSEcCtD
Cefuroxime—Irritability—Methotrexate—systemic scleroderma	0.0003	0.00114	CcSEcCtD
Cefuroxime—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.0003	0.00114	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000299	0.00113	CcSEcCtD
Cefuroxime—Nausea—Mometasone—systemic scleroderma	0.000298	0.00113	CcSEcCtD
Cefuroxime—Anorexia—Lisinopril—systemic scleroderma	0.000297	0.00113	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000297	0.00112	CcSEcCtD
Cefuroxime—Pain—Mycophenolic acid—systemic scleroderma	0.000296	0.00112	CcSEcCtD
Cefuroxime—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000296	0.00112	CcSEcCtD
Cefuroxime—Cough—Mycophenolate mofetil—systemic scleroderma	0.000292	0.00111	CcSEcCtD
Cefuroxime—Dizziness—Captopril—systemic scleroderma	0.000291	0.0011	CcSEcCtD
Cefuroxime—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00029	0.0011	CcSEcCtD
Cefuroxime—Urticaria—Leflunomide—systemic scleroderma	0.000288	0.00109	CcSEcCtD
Cefuroxime—Abdominal pain—Leflunomide—systemic scleroderma	0.000287	0.00109	CcSEcCtD
Cefuroxime—Body temperature increased—Leflunomide—systemic scleroderma	0.000287	0.00109	CcSEcCtD
Cefuroxime—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000285	0.00108	CcSEcCtD
Cefuroxime—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000285	0.00108	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000284	0.00108	CcSEcCtD
Cefuroxime—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000283	0.00107	CcSEcCtD
Cefuroxime—Hypersensitivity—Azathioprine—systemic scleroderma	0.000283	0.00107	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000283	0.00107	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000283	0.00107	CcSEcCtD
Cefuroxime—Vomiting—Captopril—systemic scleroderma	0.00028	0.00106	CcSEcCtD
Cefuroxime—Dyspnoea—Lisinopril—systemic scleroderma	0.000278	0.00105	CcSEcCtD
Cefuroxime—Rash—Captopril—systemic scleroderma	0.000278	0.00105	CcSEcCtD
Cefuroxime—Dermatitis—Captopril—systemic scleroderma	0.000277	0.00105	CcSEcCtD
Cefuroxime—Somnolence—Lisinopril—systemic scleroderma	0.000277	0.00105	CcSEcCtD
Cefuroxime—Headache—Captopril—systemic scleroderma	0.000276	0.00105	CcSEcCtD
Cefuroxime—Dyspepsia—Lisinopril—systemic scleroderma	0.000274	0.00104	CcSEcCtD
Cefuroxime—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000274	0.00104	CcSEcCtD
Cefuroxime—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000274	0.00104	CcSEcCtD
Cefuroxime—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000273	0.00104	CcSEcCtD
Cefuroxime—Decreased appetite—Lisinopril—systemic scleroderma	0.000271	0.00103	CcSEcCtD
Cefuroxime—Eosinophilia—Methotrexate—systemic scleroderma	0.000269	0.00102	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000269	0.00102	CcSEcCtD
Cefuroxime—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000267	0.00101	CcSEcCtD
Cefuroxime—Hypersensitivity—Leflunomide—systemic scleroderma	0.000267	0.00101	CcSEcCtD
Cefuroxime—Pain—Lisinopril—systemic scleroderma	0.000267	0.00101	CcSEcCtD
Cefuroxime—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000267	0.00101	CcSEcCtD
Cefuroxime—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000265	0.00101	CcSEcCtD
Cefuroxime—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000264	0.001	CcSEcCtD
Cefuroxime—Diarrhoea—Azathioprine—systemic scleroderma	0.000263	0.000996	CcSEcCtD
Cefuroxime—Haemoglobin—Prednisone—systemic scleroderma	0.000262	0.000993	CcSEcCtD
Cefuroxime—Nausea—Captopril—systemic scleroderma	0.000261	0.000991	CcSEcCtD
Cefuroxime—Haemorrhage—Prednisone—systemic scleroderma	0.000261	0.000988	CcSEcCtD
Cefuroxime—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00026	0.000987	CcSEcCtD
Cefuroxime—Pancytopenia—Methotrexate—systemic scleroderma	0.000258	0.000979	CcSEcCtD
Cefuroxime—Pruritus—Leflunomide—systemic scleroderma	0.000257	0.000973	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000255	0.000966	CcSEcCtD
Cefuroxime—Dysuria—Methotrexate—systemic scleroderma	0.000254	0.000964	CcSEcCtD
Cefuroxime—Neutropenia—Methotrexate—systemic scleroderma	0.000254	0.000964	CcSEcCtD
Cefuroxime—Dizziness—Azathioprine—systemic scleroderma	0.000254	0.000963	CcSEcCtD
Cefuroxime—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000253	0.000959	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000249	0.000943	CcSEcCtD
Cefuroxime—Diarrhoea—Leflunomide—systemic scleroderma	0.000248	0.000941	CcSEcCtD
Cefuroxime—Urticaria—Lisinopril—systemic scleroderma	0.000248	0.000939	CcSEcCtD
Cefuroxime—Abdominal pain—Lisinopril—systemic scleroderma	0.000246	0.000934	CcSEcCtD
Cefuroxime—Body temperature increased—Lisinopril—systemic scleroderma	0.000246	0.000934	CcSEcCtD
Cefuroxime—Pruritus—Mycophenolic acid—systemic scleroderma	0.000245	0.000928	CcSEcCtD
Cefuroxime—Vomiting—Azathioprine—systemic scleroderma	0.000244	0.000926	CcSEcCtD
Cefuroxime—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000244	0.000923	CcSEcCtD
Cefuroxime—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000243	0.00092	CcSEcCtD
Cefuroxime—Infestation NOS—Methotrexate—systemic scleroderma	0.000243	0.00092	CcSEcCtD
Cefuroxime—Infestation—Methotrexate—systemic scleroderma	0.000243	0.00092	CcSEcCtD
Cefuroxime—Drowsiness—Methotrexate—systemic scleroderma	0.000243	0.00092	CcSEcCtD
Cefuroxime—Rash—Azathioprine—systemic scleroderma	0.000242	0.000918	CcSEcCtD
Cefuroxime—Dermatitis—Azathioprine—systemic scleroderma	0.000242	0.000917	CcSEcCtD
Cefuroxime—Headache—Azathioprine—systemic scleroderma	0.000241	0.000912	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000241	0.000912	CcSEcCtD
Cefuroxime—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00024	0.000911	CcSEcCtD
Cefuroxime—Dizziness—Leflunomide—systemic scleroderma	0.00024	0.000909	CcSEcCtD
Cefuroxime—Renal failure—Methotrexate—systemic scleroderma	0.000238	0.000904	CcSEcCtD
Cefuroxime—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000237	0.0009	CcSEcCtD
Cefuroxime—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000237	0.000898	CcSEcCtD
Cefuroxime—Stomatitis—Methotrexate—systemic scleroderma	0.000236	0.000896	CcSEcCtD
Cefuroxime—Angiopathy—Prednisone—systemic scleroderma	0.000236	0.000896	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000236	0.000894	CcSEcCtD
Cefuroxime—Immune system disorder—Prednisone—systemic scleroderma	0.000235	0.000892	CcSEcCtD
Cefuroxime—Pain—Mycophenolate mofetil—systemic scleroderma	0.000234	0.000885	CcSEcCtD
Cefuroxime—Sweating—Methotrexate—systemic scleroderma	0.000233	0.000882	CcSEcCtD
Cefuroxime—Vomiting—Leflunomide—systemic scleroderma	0.000231	0.000874	CcSEcCtD
Cefuroxime—Hypersensitivity—Lisinopril—systemic scleroderma	0.00023	0.000871	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000229	0.00087	CcSEcCtD
Cefuroxime—Dizziness—Mycophenolic acid—systemic scleroderma	0.000229	0.000868	CcSEcCtD
Cefuroxime—Rash—Leflunomide—systemic scleroderma	0.000229	0.000867	CcSEcCtD
Cefuroxime—Dermatitis—Leflunomide—systemic scleroderma	0.000229	0.000866	CcSEcCtD
Cefuroxime—Nausea—Azathioprine—systemic scleroderma	0.000228	0.000865	CcSEcCtD
Cefuroxime—Headache—Leflunomide—systemic scleroderma	0.000227	0.000862	CcSEcCtD
Cefuroxime—Erythema—Prednisone—systemic scleroderma	0.000227	0.00086	CcSEcCtD
Cefuroxime—Agranulocytosis—Methotrexate—systemic scleroderma	0.000226	0.000858	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000223	0.000847	CcSEcCtD
Cefuroxime—Pruritus—Lisinopril—systemic scleroderma	0.000221	0.000836	CcSEcCtD
Cefuroxime—Vomiting—Mycophenolic acid—systemic scleroderma	0.00022	0.000834	CcSEcCtD
Cefuroxime—Haemoglobin—Methotrexate—systemic scleroderma	0.000219	0.00083	CcSEcCtD
Cefuroxime—Rash—Mycophenolic acid—systemic scleroderma	0.000218	0.000827	CcSEcCtD
Cefuroxime—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000218	0.000826	CcSEcCtD
Cefuroxime—Haemorrhage—Methotrexate—systemic scleroderma	0.000218	0.000826	CcSEcCtD
Cefuroxime—Hepatitis—Methotrexate—systemic scleroderma	0.000218	0.000826	CcSEcCtD
Cefuroxime—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000217	0.000822	CcSEcCtD
Cefuroxime—Headache—Mycophenolic acid—systemic scleroderma	0.000217	0.000822	CcSEcCtD
Cefuroxime—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000216	0.000818	CcSEcCtD
Cefuroxime—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000216	0.000818	CcSEcCtD
Cefuroxime—Nausea—Leflunomide—systemic scleroderma	0.000215	0.000817	CcSEcCtD
Cefuroxime—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000215	0.000815	CcSEcCtD
Cefuroxime—Urethral disorder—Methotrexate—systemic scleroderma	0.000213	0.000809	CcSEcCtD
Cefuroxime—Diarrhoea—Lisinopril—systemic scleroderma	0.000213	0.000808	CcSEcCtD
Cefuroxime—Agitation—Prednisone—systemic scleroderma	0.000208	0.00079	CcSEcCtD
Cefuroxime—Angioedema—Prednisone—systemic scleroderma	0.000207	0.000786	CcSEcCtD
Cefuroxime—Dizziness—Lisinopril—systemic scleroderma	0.000206	0.000781	CcSEcCtD
Cefuroxime—Erythema multiforme—Methotrexate—systemic scleroderma	0.000206	0.000781	CcSEcCtD
Cefuroxime—Nausea—Mycophenolic acid—systemic scleroderma	0.000206	0.000779	CcSEcCtD
Cefuroxime—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000201	0.000763	CcSEcCtD
Cefuroxime—Vomiting—Lisinopril—systemic scleroderma	0.000198	0.000751	CcSEcCtD
Cefuroxime—Angiopathy—Methotrexate—systemic scleroderma	0.000198	0.000749	CcSEcCtD
Cefuroxime—Immune system disorder—Methotrexate—systemic scleroderma	0.000197	0.000746	CcSEcCtD
Cefuroxime—Rash—Lisinopril—systemic scleroderma	0.000197	0.000745	CcSEcCtD
Cefuroxime—Convulsion—Prednisone—systemic scleroderma	0.000197	0.000745	CcSEcCtD
Cefuroxime—Dermatitis—Lisinopril—systemic scleroderma	0.000196	0.000744	CcSEcCtD
Cefuroxime—Chills—Methotrexate—systemic scleroderma	0.000195	0.000741	CcSEcCtD
Cefuroxime—Headache—Lisinopril—systemic scleroderma	0.000195	0.00074	CcSEcCtD
Cefuroxime—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000193	0.000732	CcSEcCtD
Cefuroxime—Arthralgia—Prednisone—systemic scleroderma	0.000193	0.000732	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000192	0.000727	CcSEcCtD
Cefuroxime—Erythema—Methotrexate—systemic scleroderma	0.00019	0.000719	CcSEcCtD
Cefuroxime—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000187	0.000708	CcSEcCtD
Cefuroxime—Nausea—Lisinopril—systemic scleroderma	0.000185	0.000702	CcSEcCtD
Cefuroxime—Anaphylactic shock—Prednisone—systemic scleroderma	0.000185	0.000702	CcSEcCtD
Cefuroxime—Tachycardia—Prednisone—systemic scleroderma	0.000181	0.000685	CcSEcCtD
Cefuroxime—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000181	0.000685	CcSEcCtD
Cefuroxime—Skin disorder—Prednisone—systemic scleroderma	0.00018	0.000682	CcSEcCtD
Cefuroxime—Hyperhidrosis—Prednisone—systemic scleroderma	0.000179	0.000678	CcSEcCtD
Cefuroxime—Anorexia—Prednisone—systemic scleroderma	0.000176	0.000669	CcSEcCtD
Cefuroxime—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000174	0.000658	CcSEcCtD
Cefuroxime—Rash—Mycophenolate mofetil—systemic scleroderma	0.000172	0.000653	CcSEcCtD
Cefuroxime—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000172	0.000652	CcSEcCtD
Cefuroxime—Headache—Mycophenolate mofetil—systemic scleroderma	0.000171	0.000649	CcSEcCtD
Cefuroxime—Leukopenia—Methotrexate—systemic scleroderma	0.00017	0.000643	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000169	0.000639	CcSEcCtD
Cefuroxime—Cough—Methotrexate—systemic scleroderma	0.000165	0.000627	CcSEcCtD
Cefuroxime—Convulsion—Methotrexate—systemic scleroderma	0.000164	0.000623	CcSEcCtD
Cefuroxime—Dyspepsia—Prednisone—systemic scleroderma	0.000163	0.000618	CcSEcCtD
Cefuroxime—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000162	0.000615	CcSEcCtD
Cefuroxime—Chest pain—Methotrexate—systemic scleroderma	0.000161	0.000612	CcSEcCtD
Cefuroxime—Arthralgia—Methotrexate—systemic scleroderma	0.000161	0.000612	CcSEcCtD
Cefuroxime—Decreased appetite—Prednisone—systemic scleroderma	0.000161	0.00061	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.00016	0.000608	CcSEcCtD
Cefuroxime—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000155	0.000587	CcSEcCtD
Cefuroxime—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000151	0.000574	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000151	0.000574	CcSEcCtD
Cefuroxime—Skin disorder—Methotrexate—systemic scleroderma	0.00015	0.00057	CcSEcCtD
Cefuroxime—Hyperhidrosis—Methotrexate—systemic scleroderma	0.00015	0.000567	CcSEcCtD
Cefuroxime—Anorexia—Methotrexate—systemic scleroderma	0.000147	0.000559	CcSEcCtD
Cefuroxime—Urticaria—Prednisone—systemic scleroderma	0.000147	0.000558	CcSEcCtD
Cefuroxime—Abdominal pain—Prednisone—systemic scleroderma	0.000146	0.000555	CcSEcCtD
Cefuroxime—Body temperature increased—Prednisone—systemic scleroderma	0.000146	0.000555	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000141	0.000534	CcSEcCtD
Cefuroxime—Dyspnoea—Methotrexate—systemic scleroderma	0.000138	0.000523	CcSEcCtD
Cefuroxime—Somnolence—Methotrexate—systemic scleroderma	0.000138	0.000521	CcSEcCtD
Cefuroxime—Hypersensitivity—Prednisone—systemic scleroderma	0.000136	0.000517	CcSEcCtD
Cefuroxime—Dyspepsia—Methotrexate—systemic scleroderma	0.000136	0.000516	CcSEcCtD
Cefuroxime—Decreased appetite—Methotrexate—systemic scleroderma	0.000135	0.00051	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000134	0.000506	CcSEcCtD
Cefuroxime—Pain—Methotrexate—systemic scleroderma	0.000132	0.000502	CcSEcCtD
Cefuroxime—Pruritus—Prednisone—systemic scleroderma	0.000131	0.000497	CcSEcCtD
Cefuroxime—Diarrhoea—Prednisone—systemic scleroderma	0.000127	0.00048	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000127	0.00048	CcSEcCtD
Cefuroxime—Urticaria—Methotrexate—systemic scleroderma	0.000123	0.000466	CcSEcCtD
Cefuroxime—Dizziness—Prednisone—systemic scleroderma	0.000122	0.000464	CcSEcCtD
Cefuroxime—Abdominal pain—Methotrexate—systemic scleroderma	0.000122	0.000464	CcSEcCtD
Cefuroxime—Body temperature increased—Methotrexate—systemic scleroderma	0.000122	0.000464	CcSEcCtD
Cefuroxime—Vomiting—Prednisone—systemic scleroderma	0.000118	0.000446	CcSEcCtD
Cefuroxime—Rash—Prednisone—systemic scleroderma	0.000117	0.000442	CcSEcCtD
Cefuroxime—Dermatitis—Prednisone—systemic scleroderma	0.000117	0.000442	CcSEcCtD
Cefuroxime—Headache—Prednisone—systemic scleroderma	0.000116	0.00044	CcSEcCtD
Cefuroxime—Hypersensitivity—Methotrexate—systemic scleroderma	0.000114	0.000432	CcSEcCtD
Cefuroxime—Nausea—Prednisone—systemic scleroderma	0.00011	0.000417	CcSEcCtD
Cefuroxime—Pruritus—Methotrexate—systemic scleroderma	0.000109	0.000415	CcSEcCtD
Cefuroxime—Diarrhoea—Methotrexate—systemic scleroderma	0.000106	0.000401	CcSEcCtD
Cefuroxime—Dizziness—Methotrexate—systemic scleroderma	0.000102	0.000388	CcSEcCtD
Cefuroxime—Vomiting—Methotrexate—systemic scleroderma	9.84e-05	0.000373	CcSEcCtD
Cefuroxime—Rash—Methotrexate—systemic scleroderma	9.76e-05	0.00037	CcSEcCtD
Cefuroxime—Dermatitis—Methotrexate—systemic scleroderma	9.75e-05	0.000369	CcSEcCtD
Cefuroxime—Headache—Methotrexate—systemic scleroderma	9.69e-05	0.000367	CcSEcCtD
Cefuroxime—Nausea—Methotrexate—systemic scleroderma	9.19e-05	0.000348	CcSEcCtD
